社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Icosavax, Inc.(ICVX)
15.31
+0.00
0.00%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
暂无内容
公司概况
公司名称
Icosavax, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.icosavax.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Icosavax, Inc.于2017年11月1日在特拉华州注册成立。该公司是一家生物制药公司,利用创新的病毒样颗粒(VLP)平台技术开发针对传染病的疫苗,最初的重点是威胁生命的呼吸系统疾病。该公司的VLP平台技术旨在实现复杂病毒抗原的多价、基于颗粒的显示,该公司相信这将诱导针对特定目标病毒的广泛、强大和持久的保护。该公司的产品包括针对一些最常见的肺炎病毒性病因的候选疫苗。该公司正在为老年人开发这些候选药物,这是一个有很高需求未得到满足的患者群体。该公司的主要候选疫苗IVX-A12是一种二价候选疫苗,或两种不同VLP候选疫苗的混合物。
2024-02-21
超过5%披露
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024-02-21
超过5%披露
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024-02-20
交易所摘牌声明
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024-02-20
员工持股计划
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-02-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-02-14
超过5%披露
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024-02-14
超过5%披露
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024-01-11
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-01-05
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2023-12-22
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2023-12-22
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2023-12-21
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2023-12-21
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2023-12-21
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2023-12-21
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
分时
5日
日
周
月
数据加载中...
最高
15.31
今开
15.31
量比
0.00
最低
15.31
昨收
15.31
换手率
0.00%
热议股票
{"pagemeta":{"title":"Icosavax, Inc.(ICVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Icosavax, Inc.(ICVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Icosavax, Inc.,ICVX,Icosavax, Inc.股票,Icosavax, Inc.股票老虎,Icosavax, Inc.股票老虎国际,Icosavax, Inc.行情,Icosavax, Inc.股票行情,Icosavax, Inc.股价,Icosavax, Inc.股市,Icosavax, Inc.股票价格,Icosavax, Inc.股票交易,Icosavax, Inc.股票购买,Icosavax, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Icosavax, Inc.(ICVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Icosavax, Inc.(ICVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"ICVX","data":{"stockData":{"symbol":"ICVX","market":"US","secType":"STK","nameCN":"Icosavax, Inc.","latestPrice":15.31,"timestamp":1708117200000,"preClose":15.31,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":29720875,"shares":50802709,"eps":-2.19469,"marketStatus":"停牌","change":0,"latestTime":"01-15 15:58:45 EST","open":15.31,"high":15.31,"low":15.31,"amount":142682289.453564,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.19469,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768510800000},"marketStatusCode":2,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":15.31,"volumeRatio":0},"tweetData":{"bottom":true,"list":[],"size":0},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"17617387","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924026050-ICVX","pdf_url":"","pub_time":1708491600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","symbol":"ICVX","title":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924026050/0001104659-24-026050-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SC 13D/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924026050/tm246806d1_sc13da.htm","primary":true,"translateUrl":"","linkName":"tm246806d1_sc13da.htm","type":"SC 13D/A","id":"NTFILECuBJ6PSwRRHeabRz","market":"us","size":72095}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-21 13:00","pubTimestamp":1708491600,"title_zh":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17617319","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924026047-ICVX","pdf_url":"","pub_time":1708491600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","symbol":"ICVX","title":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924026047/0001104659-24-026047-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SC 13D/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1346824/000110465924026047/tm246819d1_sc13da.htm","primary":true,"translateUrl":"","linkName":"tm246819d1_sc13da.htm","type":"SC 13D/A","id":"NTFILE8LGZmjoGP5DxGLHw","market":"us","size":87029}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-21 13:00","pubTimestamp":1708491600,"title_zh":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17612964","market":"us","labels":[],"media":"sec.gov","original_id":"AN135445724000098-ICVX","pdf_url":"","pub_time":1708405200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","symbol":"ICVX","title":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","titleType":"交易所摘牌声明","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/000135445724000098/0001354457-24-000098-index.htm","us_notice_code":"Form 25-NSE","us_title_en":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1354457/000135445724000098/xslF25X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"25-NSE","id":"NTFILE9fmjUZ3fR6VcpgiE","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Delisting","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"交易所摘牌声明","pubTime":"2024-02-20 13:00","pubTimestamp":1708405200,"title_zh":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17612775","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924025259-ICVX","pdf_url":"","pub_time":1708405200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ICVX","title":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924025259/0001104659-24-025259-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"S-8 POS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924025259/tm246604-2_s8pos.htm","primary":true,"translateUrl":"","linkName":"tm246604-2_s8pos.htm","type":"S-8 POS","id":"NTFILEDLMcZ4Nx7J4jGQ6K","market":"us","size":25053}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2024-02-20 13:00","pubTimestamp":1708405200,"title_zh":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17612768","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924025251-ICVX","pdf_url":"","pub_time":1708405200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ICVX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924025251/0001104659-24-025251-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.01: Completion of Acquisition or Disposition of Assets;\nItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 3.03: Material Modifications to Rights of Security Holders;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"EXHIBIT 3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924025251/tm246604d3_ex3-1.htm","primary":true,"translateUrl":"","linkName":"tm246604d3_ex3-1.htm","type":"EX-3.1","id":"NTFILEH683Y5VTA3njEb7A","market":"us","size":7496},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924025251/tm246604d3_8k.htm","primary":false,"translateUrl":"","linkName":"tm246604d3_8k.htm","type":"8-K","id":"NTFILE3Et7zy92f5nfYS9P","market":"us","size":48576},{"description":"EXHIBIT 3.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924025251/tm246604d3_ex3-2.htm","primary":false,"translateUrl":"","linkName":"tm246604d3_ex3-2.htm","type":"EX-3.2","id":"NTFILE5jMjLbNKCQUUve6a","market":"us","size":58050}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-02-20 13:00","pubTimestamp":1708405200,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17599369","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266424001660-ICVX","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"ICVX","title":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/000090266424001660/0000902664-24-001660-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"ICOSAVAX, INC.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1425851/000090266424001660/p24-0799sc13g.htm","primary":true,"translateUrl":"","linkName":"p24-0799sc13g.htm","type":"SC 13G","id":"NTFILE8egyB1yY6ckRS838","market":"us","size":61789},{"description":"JOINT ACQUISITION STATEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1425851/000090266424001660/p24-0799exhibit99.htm","primary":false,"translateUrl":"","linkName":"p24-0799exhibit99.htm","type":"EX-99.1","id":"NTFILE2n4i94NzQ71t5UEj","market":"us","size":4486}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17599366","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924023963-ICVX","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"ICVX","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/000110465924023963/0001104659-24-023963-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SC 13G/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1423053/000110465924023963/tm243953d6_sc13ga.htm","primary":true,"translateUrl":"","linkName":"tm243953d6_sc13ga.htm","type":"SC 13G/A","id":"NTFILE3ZaxeZtP9UU7YLyB","market":"us","size":137065}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17732655","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312524006127-ICVX","pdf_url":"","pub_time":1704936745000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ICVX","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0001193125-24-006127-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000119312524006127/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEko5qSFVY564vqJkP","market":"us","size":16239},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000119312524006127/g92581dsp4.jpg","primary":false,"translateUrl":"","linkName":"g92581dsp4.jpg","type":"GRAPHIC","id":"NTFILEGhj9XXNq4RstxGpU","market":"us","size":11029},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000119312524006127/g92581dsp4a.jpg","primary":false,"translateUrl":"","linkName":"g92581dsp4a.jpg","type":"GRAPHIC","id":"NTFILEE9sgTYJHx8QfpT2r","market":"us","size":6424}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-01-11 09:32","pubTimestamp":1704936745,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17425530","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004724000173-ICVX","pdf_url":"","pub_time":1704405137000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ICVX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0001950047-24-000173-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000195004724000173/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8jUVSng2UJF4hkot","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-01-05 05:52","pubTimestamp":1704405137,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17380343","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004723006411-ICVX","pdf_url":"","pub_time":1703194924000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ICVX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0001950047-23-006411-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000195004723006411/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE2iEdaRQk52qBwRU1","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2023-12-22 05:42","pubTimestamp":1703194924,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17380342","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004723006407-ICVX","pdf_url":"","pub_time":1703194129000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ICVX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0001950047-23-006407-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000195004723006407/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8ytnvUrtp7GknGV2","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2023-12-22 05:28","pubTimestamp":1703194129,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17375238","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017023072027-ICVX","pdf_url":"","pub_time":1703123647000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ICVX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0000950170-23-072027-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000095017023072027/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEBfRMykTkzfFU7q7B","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2023-12-21 09:54","pubTimestamp":1703123647,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17375237","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017023072025-ICVX","pdf_url":"","pub_time":1703123432000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ICVX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0000950170-23-072025-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000095017023072025/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEE42a1uQS9rYmQNPm","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2023-12-21 09:50","pubTimestamp":1703123432,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17375236","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017023072024-ICVX","pdf_url":"","pub_time":1703123419000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ICVX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0000950170-23-072024-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000095017023072024/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8Rbmw8YucYPYZLxT","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2023-12-21 09:50","pubTimestamp":1703123419,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17375235","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017023072023-ICVX","pdf_url":"","pub_time":1703123071000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ICVX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1786255/0000950170-23-072023-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1786255/000095017023072023/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEEba5EtrH6wWYHzR5","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2023-12-21 09:44","pubTimestamp":1703123071,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.icosavax.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.045},{"period":"6month","weight":0.1},{"period":"1year","weight":0.1858},{"period":"ytd","weight":0.0124}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Icosavax, Inc.于2017年11月1日在特拉华州注册成立。该公司是一家生物制药公司,利用创新的病毒样颗粒(VLP)平台技术开发针对传染病的疫苗,最初的重点是威胁生命的呼吸系统疾病。该公司的VLP平台技术旨在实现复杂病毒抗原的多价、基于颗粒的显示,该公司相信这将诱导针对特定目标病毒的广泛、强大和持久的保护。该公司的产品包括针对一些最常见的肺炎病毒性病因的候选疫苗。该公司正在为老年人开发这些候选药物,这是一个有很高需求未得到满足的患者群体。该公司的主要候选疫苗IVX-A12是一种二价候选疫苗,或两种不同VLP候选疫苗的混合物。","exchange":"NASDAQ","name":"Icosavax, Inc.","nameEN":"Icosavax, Inc."},"aProfile":null}}}